Biogen ends Tecfidera DTC campaign, citing prescriptions

The drugmaker had launched the campaign for the multiple sclerosis drug in 2015.

MM&M's 2016 Top 100 Agencies

Here's everything you need to know about the 2015 performance of the top 100 healthcare agencies, including revenue, trends, and what the CEOs say.

Five things for pharma marketers to know: Friday, July 22, 2016

Five things for pharma marketers to know: Friday, July 22, 2016

Herceptin biosimilar meets endpoint in clinical trial; Roche plans to launch five new drugs over the next year; government seeks to block insurer deals

Novartis ups marketing investment in Entresto, by $200 million

Novartis ups marketing investment in Entresto, by $200 million

One oft-cited challenge to Entresto's adoption has been prior authorization requirements.

Avanir marketing chief on selling first-in-class therapies

Avanir marketing chief on selling first-in-class therapies

Avanir's success with Nuedexta sparked the attention of several suitors. In 2014 the company reached a deal to be sold to Otsuka Pharmaceutical for around $3.5 billion

Five things for pharma marketers to know: Thursday, July 21, 2016

Five things for pharma marketers to know: Thursday, July 21, 2016

The FDA approves generic versions of AstraZeneca's Crestor; Biogen CEO steps down; drugmakers race to develop smart inhalers

Five things for pharma marketers to know: Wednesday, July 20, 2016

Five things for pharma marketers to know: Wednesday, July 20, 2016

Spending on CME rose in 2015; the FDA approves Valeant's Relistor; the Justice Department aims to block insurer merger

Why competing agencies are joining forces to give parents more time off

Why competing agencies are joining forces to give parents more time off

Twenty shops, including Co:Collective, Wolff Olins, and 72andSunny, have signed onto the Pledge Parental Leave coalition since March.

Five things for pharma marketers to know: Tuesday, July 19, 2016

Five things for pharma marketers to know: Tuesday, July 19, 2016

The FDA declines to approve Novartis biosimilar; GSK partners with Apple's ResearchKit; drugmakers partner with Lyft for clinical trial participants

ZS' Pete Mehr on embracing and adapting to change

ZS' Pete Mehr on embracing and adapting to change

Mehr was recently promoted to lead customer-centric marketing solutions at ZS Associates.

Five things for pharma marketers to know: Monday, July 18, 2016

Five things for pharma marketers to know: Monday, July 18, 2016

Roche's blood cancer drug fails to meet trial goal; the FDA says Valeant's psoriasis drug carries risk of suicide; Facebook tests disappearing messages

At Work With: ContextMedia:Health's Ashik Desai

At Work With: ContextMedia:Health's Ashik Desai

The health technology company's EVP of business growth and analytics talks about his career path, from studying medicine to leading ContextMedia:Health's commercial solutions team.

Five things for pharma marketers to know: Friday, July 15, 2016

Five things for pharma marketers to know: Friday, July 15, 2016

PhRMA brings on new members, Amgen partners with Daiichi Sankyo on biosimilar commercialization in Japan; Thomson Reuters to sell science unit

Arnold's Gary Scheiner to lead creative at ghg

Arnold's Gary Scheiner to lead creative at ghg

Scheiner has held jobs in and out of healthcare over the course of his career.

Five things for pharma marketers to know: Thursday, July 14, 2016

Five things for pharma marketers to know: Thursday, July 14, 2016

The FDA expands use for Pfizer's Prevnar 13 vaccine; an FDA panel votes in support of Novartis biosimilar; U.S. healthcare spending rises 5.5% in 2015

Asia-Pacific to overtake North America in ad spending

Asia-Pacific to overtake North America in ad spending

Globally, digital ad spend this year is expected to grow by 12.6% to $176.7 billion, accounting for 32% of all ad spend.

Five things for pharma marketers to know: Wednesday, July 13, 2016

Five things for pharma marketers to know: Wednesday, July 13, 2016

Gilead reportedly avoiding paying billions in taxes; Merck plans to cut R Sage's treatment for postpartum depression meets trial goal

Digitas Health LifeBrands partners with startup accelerator Dreamit

Digitas Health LifeBrands partners with startup accelerator Dreamit

The partnership is aimed at helping later-stage health startups grow their businesses with marketing and brand strategy advice.

Five things for pharma marketers to know: Tuesday, July 12, 2016

Five things for pharma marketers to know: Tuesday, July 12, 2016

U.S. cancer centers triple spending on advertising; study finds patient choice can reduce side effects; the FDA approves Shire's dry-eye drug

Astellas hires Joseph Devaney as government affairs VP

Astellas hires Joseph Devaney as government affairs VP

He is replacing Martin Golden, who was appointed head of global marketing strategy.

Agency Spotlight


OPINION

Email Newsletters